Product development: Offering Viagra in a nasal spray, rubbing ointment, and chewable form. Pros: Demonstrates that Pfizer is constantly at the cutting edge of technology. Cons: Expensive form of marketing. Customers may not perceive the chewable form as a serious medication alternative. A variety of products might confuse and discourage customers.
Market penetration: Positioning itself as the first pharmaceutical company to address and treat impotence. Pros: It is the most cost effective method in to maintain sales. Cons: Competition might enter other segments of market, while Pfizer is focusing on existing markets.
Market development: Expand demographics to attract the younger-aged men who are in relationships that are sexually active that use condoms and experience erectile dysfunction. Pros: Widens distribution channel and increases company exposure as the leading firm to treat impotence. Cons: Attracting the younger-aged population might give the public the perception that Pfizer is only interested in increasing profit.
Product diversification: Joint venture with the Impotence Association to abolish the social stigma of feeling embarrassed to discuss impotence. Pros: Synergistic partnership enhances credibility and is a cost effective form of marketing. Cons: Goals between firms might conflict.
3.4.
Evaluation: In regards to product development many people might not feel comfortable or have problems taking pills for treatment, where they can now resort to different methods of treatment like the ointments, sprays, and chewable tablets. Even though it might cost Pfizer money in the early stages of these new product developments, it will surely increase revenue in the future.
Pfizer is known for its trademark (Viagra), which has totally given the company an edge over all other pharmaceutical companies and will maintain its sales even if other companies due enter the market. Pfizer will have the customer database which will not resort to other companies due to the great customer service and innovation Pfizer offers.
(Hensley) As a result, Pfizer Inc. presents an experimental pill to help people quit smoking. ... In competition with Pfizer is Zyban. ... Another competitor to Pfizer is Sanofi-Synthelabo of France. ... Along with the few other major drug-makers, Pfizer competes in an oligopolistic market. ... "Pfizer's Hopes: Antismoking Pill" The Wall Street Journal 17 June 2003: B1 , B11. ...
As Pfizer, a multinational corporation, we have certain ethical responsibilities. ... As a manager at Pfizer, I have to develop certain ethics. ... Credit is often pulled up in an organization like Pfizer. ... In Pfizer, there are many managerial circles. ... Pfizer should encourage ethical behavior and they can do so in multiple ways. ...
Pfizer, Inc. ... As the most senior physician at Pfizer, Dr. ... Pfizer has also developed an enhanced commercial operating structure. ... Pfizer and the Pfizer Foundation established the Global Health Partnership Program to help support local and regional cancer-awareness and smoking-cessation programs. ... Pfizer's Helpful Answers is a family of assistance programs for uninsured and underinsured patients who need help getting their Pfizer medicines. ...
When pharmaceutical companies such as Pfizer and GlaxoSmithKline do drug testing on new drugs and think that these new drugs are going to be great successes, they usually let their investors know and publicize this success. ... In the case of the drug CP-122,721, a new drug in the lucrative depression field that "offers strong efficacy with fewer of the side effects", the Pfizer company said nothing to its investors when this drug became cancelled. Instead of notifying investors, Pfizer said nothing and let the drug disappear. ...
Zoloft is made and marketed by Pfizer. Pfizer is 150 years old, has over 120,000 employees and span over 6 continents. ... Pfizer's sales for their last fiscal year were $45 billion in 2002. ... In 2003, Pfizer has budgeted $7.1 billion in R & D. The medicines library includes approximately 2 million compounds, and Pfizer's pipeline holds more than 160 projects in development and over 300 projects in discovery research in 18 therapeutic areas (Pfizer 2). ...
Pfizer, a healthcare company that started in New York has expanded its company to the United Kingdom, and it is the largest company used in the United Kingdom. ... Pfizer has developed and transform 100 different types of medicine, vaccines and other healthcare products that have helped saved lives all over the world. It takes Pfizer about twelve years to create a new medicine. ... Pfizer holds annual worldwide safety groups which allow other countries to come into Pfizer to be taught how patients should be dealt with different kinds of health care products. ... They should add the company P...
The company Pfizer, USA is located in New York. ... In my opinion a company such as Pfizer, USA is a good example of having an out of control profit margin at 42%! ... In 2013 when the profit was so high for Pfizer, USA, their Research and Development costs consisted of 12.9% of their profit margin, for 2014 it did go up to 16.9%. ... In my opinion our capitalistic system does not easily balance the power between the consumer of the product and the large corporate pharmaceutical companies, such as Pfizer, USA. ...
The major drug companies involved in this debate are Myers Squibb, Glaxo Smith Kline, Abbott Laboratories, Pfizer, among others. I have chosen to base my research in this section around the pharmaceutical company Pfizer. ... Pfizer prices one days' worth of an AIDS related drug (AZT, DDI, DDC, are the most common) at over $20. ...
Pfizer, the pharmaceutical company, is wanting to disclose more information on the procedures and testing of their medicines and what their follow-up is. Here in the U.S., Pfizer has helped over 53 million Americans, without insurance, get medicine for free or reduced price (Kindler). In other countries, Pfizer was giving away 87 million treatments to prevent blindness in poorer countries. ...
